Discovery may open door for treating fragile X carriers
Fragile X syndrome, an inherited cause of autism and intellectual disability, can have consequences even
for carriers of the disorder who don’t have full-blown symptoms. Researchers at Washington University School of Medicine in St. Louis have identified
a potential target for treatment for fragile X carriers.
Fatal cell malfunction ID’d in Huntington’s disease
New research from the School of Medicine’s Albert Kim, MD, PhD (left), and Hiroko Yano, PhD, helps explain how mutations in the gene that causes Huntington’s disease kill brain cells. The findings could open new opportunities for treating the fatal disorder.
Investigational drugs chosen for major Alzheimer’s prevention trial
Leading scientists have selected the first drugs to
be evaluated in a worldwide clinical trial to determine whether they can
prevent Alzheimer’s disease. The pioneering trial, expected to
start by early 2013, initially will test three promising drugs, each
designed to target Alzheimer’s in different ways.